Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-040864
Filing Date
2021-10-20
Accepted
2021-10-20 19:02:58
Documents
1
Period of Report
2021-10-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3511
  Complete submission text file 0000899243-21-040864.txt   5335
Mailing Address 3 FORBES ROAD LEXINGTON MA 02421
Business Address 3 FORBES ROAD LEXINGTON MA 02421 781-674-4410
AGENUS INC (Reporting) CIK: 0001098972 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40908 | Film No.: 211335243
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 212-994-8250
MiNK Therapeutics, Inc. (Issuer) CIK: 0001840229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)